BlackRock Fund Advisors’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$272K Buy
75,721
+2,308
+3% +$10.3K ﹤0.01% 3349
2016
Q3
$382K Buy
73,413
+1,362
+2% +$4.42K ﹤0.01% 3288
2016
Q2
$118K Buy
72,051
+15,305
+27% +$26.6K ﹤0.01% 3620
2016
Q1
$95K Sell
56,746
-3,993
-7% -$8.04K ﹤0.01% 3677
2015
Q4
$128K Buy
60,739
+2,666
+5% +$5.15K ﹤0.01% 3675
2015
Q3
$113K Sell
58,073
-1,536
-3% -$3.52K ﹤0.01% 3667
2015
Q2
$166K Buy
59,609
+12,247
+26% +$33.7K ﹤0.01% 3594
2015
Q1
$113K Sell
47,362
-3,216
-6% -$10.7K ﹤0.01% 3599
2014
Q4
$186K Buy
50,578
+3,618
+8% +$14.1K ﹤0.01% 3503
2014
Q3
$187K Sell
46,960
-3,417
-7% -$13.9K ﹤0.01% 3493
2014
Q2
$183K Buy
50,377
+1,440
+3% +$5.82K ﹤0.01% 3519
2014
Q1
$191K Buy
48,937
+5,940
+14% +$17.5K ﹤0.01% 3479
2013
Q4
$92K Buy
42,997
+1,800
+4% +$4.39K ﹤0.01% 3581
2013
Q3
$116K Buy
41,197
+3,240
+9% +$9.91K ﹤0.01% 3526
2013
Q2
$112K Buy
+37,957
New +$128K ﹤0.01% 3501

Other funds holding APYX

BlackRock Fund Advisors's APYX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Apyx Medical (APYX) stake by 3.1% in Q4 2016, buying an estimated $10.3K and bringing the position to 75,721 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

BlackRock Fund Advisors first reported a position in APYX in Q2 2013 and has held it in 15 quarters since. The position peaked at $382K in Q3 2016. 39 funds tracked by Wall St. Rank hold APYX as of Q4 2016.

  • BlackRock Fund Advisors held 75,721 shares of Apyx Medical worth $272K as of Q4 2016.
  • BlackRock Fund Advisors bought 2,308 Apyx Medical shares in Q4 2016, an estimated $10.3K.
  • Apyx Medical made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3349 holding.
  • BlackRock Fund Advisors first reported a position in Apyx Medical in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Apyx Medical position peaked at $382K in Q3 2016.
  • 39 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.